Does anyone have experience obtaining sunvozertinib in the second-line setting for patients with EGFR exon 20 insertion mutations?  

I have not. Though FDA-approved for months, the drug has not been available for dispensation. Dizal has not had a US presence and has not yet established a distribution partnership. Currently available in China - hoping for access in the US any day now.